Idea principal
In 122 clinic patients, a handheld ECG, the Apple Watch ECG and two phone camera apps each detected atrial fibrillation (AF) with 100% sensitivity, and specificity for sinus rhythm ranged from 96.4% to 98.9%. Only 30 patients had AF, and 7.4% to 14.8% of recordings were of insufficient quality.
Study design
Estudio/revisión de validación
Reading basis
Published abstract
Reading focus
Reference & error
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Smartwatches and phones now claim to detect atrial fibrillation, an irregular heart rhythm that raises stroke risk, but most validation studies test one device at a time. The authors compared four consumer devices head-to-head against a hospital-grade 12-lead ECG in the same people.
Población y método
Patients with sinus rhythm or AF were enrolled at a cardiology outpatient clinic. In random order each took a measurement with a handheld 6-lead ECG (KardiaMobile 6L), a smartwatch single-lead ECG (Apple Watch) and two smartphone photoplethysmography (PPG, light-based pulse) apps (FibriCheck and Preventicus), while a simultaneous 12-lead ECG served as the reference. The abstract does not name the country.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1122 participants took part (median age 69 years, IQR 61-77; 78 men, 63.9%; 30 with AF, 25%).
- 2Sensitivity for detecting AF was 100% for all four devices.
- 3Specificity for recognizing sinus rhythm was 96.4% (95% CI 89.5%-98.8%) for KardiaMobile 6L, 97.8% (91.6%-99.5%) for Apple Watch, 98.9% (92.5%-99.8%) for FibriCheck and 97.8% (91.5%-99.4%) for Preventicus; the difference between devices was not significant (P=.50).
- 4Recordings of insufficient quality occurred in 10.7% for both KardiaMobile 6L and Apple Watch, 7.4% for FibriCheck and 14.8% for Preventicus (P=.21). Participants preferred the Apple Watch.
Límites e incertidumbre
- 1With only 30 patients in AF, the 100% sensitivity comes with a wide possible range, and the abstract does not give a confidence interval for it.
- 2Participants were cardiology clinic patients who were told how to measure, so results may be better than for people using the devices unprompted in daily life.
- 3The study compared single spot checks against a 12-lead ECG, not long-term monitoring for paroxysmal (come-and-go) AF.
- 4This reading is based on the abstract only.
Relevancia práctica
These results suggest that ECG- and PPG-based consumer tools can tell a clean AF recording from normal rhythm well when the recording is good. They do not show how often a device would catch brief AF at home, and an alert still needs confirmation by a clinician with a medical-grade ECG.
Tus datos
If your watch or phone offers rhythm checks, take them seated and still, using the same device and method each time, and expect some recordings to be rejected as unreadable. A flagged irregular rhythm is a reason to contact a clinician, not a diagnosis.
Cómo interpretar la evidencia
Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Consumer-oriented wearable devices (CWDs) such as smartphones and smartwatches have gained prominence for their ability to detect atrial fibrillation (AF) through proprietary algorithms using electrocardiography or photoplethysmography (PPG)-based digital recordings. Despite numerous individual validation studies, a direct comparison of interdevice performance is lacking.
Objective
This study aimed to evaluate and compare the ability of CWDs to distinguish between sinus rhythm and AF.
Methods
Patients exhibiting sinus rhythm or AF were enrolled through a cardiology outpatient clinic. The participants were instructed to perform heart rhythm measurements using a handheld 6-lead electrocardiogram (ECG) device (KardiaMobile 6L), a smartwatch-derived single-lead ECG (Apple Watch), and two PPG-based smartphone apps (FibriCheck and Preventicus) in a random sequence, with simultaneous 12-lead reference ECG as the gold standard.
Results
A total of 122 participants were included in the study: median age 69 (IQR 61-77) years, 63.9% (n=78) men, 25% (n=30) with AF, 9.8% (n=12) without prior smartphone experience, and 73% (n=89) without experience in using a smartwatch. The sensitivity to detect AF was 100% for all devices. The specificity to detect sinus rhythm was 96.4% (95% CI 89.5%-98.8%) for KardiaMobile 6L, 97.8% (95% CI 91.6%-99.5%) for Apple Watch, 98.9% (95% CI 92.5%-99.8%) for FibriCheck, and 97.8% (95% CI 91.5%-99.4%) for Preventicus (P=.50). Insufficient quality measurements were observed in 10.7% (95% CI 6.3%-17.5%) of cases for both KardiaMobile 6L and Apple Watch, 7.4% (95% CI 3.9%-13.6%) for FibriCheck, and 14.8% (95% CI 9.5%-22.2%) for Preventicus (P=.21). Participants preferred Apple Watch over the other devices to monitor their heart rhythm.
Conclusions
In this study population, the discrimination between sinus rhythm and AF using CWDs based on ECG or PPG was highly accurate, with no significant variations in performance across the examined devices.
Fuentes y atribución
Comparative Evaluation of Consumer Wearable Devices for Atrial Fibrillation Detection: Validation Study.
Wouters F, Gruwez H, Smeets C, Pijalovic A, Wilms W, Vranken J, Pieters Z, Van Herendael H, Nuyens D, Rivero-Ayerza M, Vandervoort P, Haemers P, Pison L.
JMIR formative research · 2025-01-09
DOI: 10.2196/65139 ↗PubMed · 39791483 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

